Merck | MRK - Przychody Ze Sprzedaży





Obroty Zmiana Data
Adidas EUR 6.74B 150M 2026-06
Adyen EUR 1.42B 329.01M 2025-12
Akzo Nobel EUR 2.59B 200M 2026-06
Alcon AG USD 2.78B 90M 2026-06
Amadeus IT EUR 1.65B 30M 2026-06
Amarin USD 49.22M 451K 2025-12
AstraZeneca USD 15.38B 90M 2026-06
BASF EUR 17.21B 1.19B 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Beiersdorf EUR 2.45B 30M 2026-06
Covestro EUR 6.73B 3.82B 2026-06
Danone EUR 7.22B 510M 2026-06
Fresenius EUR 5.95B 210M 2026-06
Fresenius Medical Care EUR 4.86B 250M 2026-06
Genmab DKK 1.16B 259M 2026-06
Givaudan CHF 3.61B 256M 2025-12
GlaxoSmithKline GBP 8.41B 781M 2026-06
GRIFOLS EUR 1.87B 170M 2026-06
Henkel EUR 10.35B 255M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Infineon EUR 4.17B 360M 2026-06
Lakefront Biotherapeutics EUR 12.11M 5.61M 2026-06
Linde USD 8.78B 17M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.43B 300M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Philips EUR 4.36B 450M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.95B 710M 2026-06
UCB EUR 4.25B 764M 2025-12